This inventor holds 1 USPTO granted patent. Top assignee: Bayer Aktiengesellschaft. Active years: 1987.
Company Filing History:
Years Active: 1987
Title: Bernd Schade: Innovator in Prostaglandin Complexes
Introduction
Bernd Schade is a notable inventor based in Cologne, Germany. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on prostaglandin complexes. His expertise and dedication to research have led to advancements that benefit the medical community.
Latest Patents
One of Bernd Schade's key patents is focused on "Complexes of Prostaglandins." This invention relates to the development of complexes that combine prostaglandins with crosspovidone, pre-pasted starch, or dextrans. The patent outlines a process for preparing these complexes and discusses their use in medicaments and pharmaceutical formulations. This work highlights the potential for improved therapeutic applications in medicine.
Career Highlights
Bernd Schade is associated with Bayer Aktiengesellschaft, a leading global pharmaceutical and life sciences company. His role at Bayer has allowed him to collaborate with other experts in the field and contribute to groundbreaking research. His patent portfolio reflects his commitment to innovation and the advancement of medical science.
Collaborations
Throughout his career, Bernd has worked alongside esteemed colleagues such as Bernhard Streuff and Detlef Mathes. These collaborations have fostered a productive environment for research and development, leading to significant advancements in their respective fields.
Conclusion
In summary, Bernd Schade is a distinguished inventor whose work on prostaglandin complexes has the potential to impact the pharmaceutical industry positively. His contributions, along with his collaborations, underscore the importance of innovation in medicine.